Beam Therapeutics Inc. (BEAM) is listed on NASDAQ in Biotech Stocks. It is $29.29, -3.90%, with a $3.0B market cap. RSI is 55.7, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 55.7 Neutral
Market Cap $3.0B
Volume 948.2K
Fundamentals — 10-Q Q2 2026
Revenue $32.2M
Net Income $-217.0M
EPS $-2.09
Operating Margin -725.4%
Net Margin -673.3%
Debt / Equity 0.1x
P/E Ratio -14.0x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Simon Amy | Chief Medical Officer | Sell | 16,667 | $25.74 | $429,037 | 2026 Jul 27 |
| Evans John M. | CEO | Sell | 50,000 | $34.90 | $1.7M | 2026 Jun 30 |
| Fmr LLC | Insider | Sell | 284,860 | $35.24 | $10.0M | 2026 Jun 26 |
| Evans John M. | CEO | Sell | 30,078 | $24.58 | $739,317 | 2026 Apr 1 |
| Simon Amy | Chief Medical Officer | Sell | 6,700 | $24.58 | $164,686 | 2026 Apr 1 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,242 | $24.58 | $79,688 | 2026 Apr 1 |
| Bellon Christine | Chief Legal Officer | Sell | 5,956 | $24.58 | $146,398 | 2026 Apr 1 |
| Ciaramella Giuseppe | President | Sell | 11,810 | $24.58 | $290,290 | 2026 Apr 1 |
| Evans John M. | CEO | Sell | 50,000 | $22.57 | $1.1M | 2026 Mar 31 |
| Ciaramella Giuseppe | President | Sell | 35,000 | $32.00 | $1.1M | 2026 Feb 24 |
| Fmr LLC | 10% Owner | Sell | 459 | $26.68 | $12,246 | 2025 Oct 27 |
| Evans John M. | CEO | Sell | 50,000 | $24.57 | $1.2M | 2025 Oct 2 |
| Bellon Christine | Chief Legal Officer | Sell | 373 | $24.53 | $9,150 | 2025 Oct 1 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 467 | $24.53 | $11,456 | 2025 Oct 1 |
| Fmr LLC | 10% Owner | Sell | 48,374 | $20.50 | $991,667 | 2025 Jul 30 |
| Simon Amy | Chief Medical Officer | Sell | 1,250 | $19.17 | $23,961 | 2025 Jul 3 |
| Simon Amy | Chief Medical Officer | Sell | 30,563 | $17.92 | $547,813 | 2025 Apr 2 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | 3,015 | $18.35 | $55,325 | 2025 Apr 1 |
| Bellon Christine | Chief Legal Officer | Sell | 5,674 | $18.35 | $104,118 | 2025 Apr 1 |
| Ciaramella Giuseppe | President | Sell | 7,434 | $18.35 | $136,414 | 2025 Apr 1 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $3.33 | 53.9 | $1.8B |
Take BEAM further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BEAM in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Beam Therapeutics Inc. next reports.
Set alerts on BEAM
Get notified when Beam Therapeutics Inc. hits your price targets or technical conditions are met.
Get Started Free